- Added to Email Alerts
Multiple Myeloma
Latest News View All
-
In Remission for 10 Years: Long-term Toxicity Data on CAR T Cells -
Belantamab for MM: Benefit Outweighs Ocular Risk, FDA Panel Says
-
EHA 2020New Option for AL Amyloidosis: Daratumumab Added to CyBorD
-
Transplant Beats Bortezomib-Based Therapy for MM
-
Subcutaneous Daratumumab Effective Alternative to IV Formulation for Multiple Myeloma
-
COVID-19 Antibody Tests Proliferate, but What Do They Show?
-
Life in the 'Cabin': Two Months Fighting COVID-19 in Wuhan
-
Genetic Test Identifies Ultra-High-Risk Myeloma Patients
Perspective View All
Journal Articles View All
-
Venetoclax/carfilzomib/dexamethasone in Refractory MM
-
Next-Gen Sequencing in the Evaluation of Hematologic Neoplasms
-
Scores Underestimate Survival in Metastatic Spine Disease
-
Autologous Stem-Cell Transplantation for Multiple Myeloma
-
Calprotectin for Discrimination of Septic Arthritis
-
Laboratory Evaluation of Peripheral Neuropathy
Additional Resources
Medscape Drugs & Diseases
- Multiple Myeloma
- Light Chain-Associated Renal Disorders
- Immunoglobulin-Related Amyloidosis
- Monoclonal Gammopathies of Uncertain Origin
- Hyperviscosity Syndrome
Medscape Education